In our studies, we investigated the in vitro effects of pantoprazole, as a representative of the proton pump inhibitors, on both osteoblasts and osteoclasts. Our experiments revealed increased viability and synthetic activity of osteoblasts and, contrarily, decreased viability and resorptive activity of osteoclasts after stimulation with pantoprazole. In this context, osteoporosis through cellular impairment seems an unlikely potential cause for an increased fracture risk under proton pump inhibitor therapy.
«
In our studies, we investigated the in vitro effects of pantoprazole, as a representative of the proton pump inhibitors, on both osteoblasts and osteoclasts. Our experiments revealed increased viability and synthetic activity of osteoblasts and, contrarily, decreased viability and resorptive activity of osteoclasts after stimulation with pantoprazole. In this context, osteoporosis through cellular impairment seems an unlikely potential cause for an increased fracture risk under proton pump inhib...
»